Explore the categories so you can find more about your search.

Categorie > Blood / Hematology

Some Anemia Treatment Agents Increase Risk Of Blood Clots And Death In Cancer Patients

Categorie : Blood / Hematology
Using erythropoiesis-stimulating agents (ESAs) in thetreatment of anemia increases the risk of venous thromboembolism (VTE)and death among cancer patients, according to an article in theFebruary 27, 2008 issue of JAMA.ESAs are a class of drugs that promote red blood cell production in thebody. The E ...

read more Using erythropoiesis-stimulating agents (ESAs) in thetreatment of anemia increases the risk of venous thromboembolism (VTE)and death among cancer patients, according to an article in theFebruary 27, 2008 issue of JAMA.ESAs are a class of drugs that promote red blood cell production in thebody. The E read more Wed Mar 2008 Wed Mar 2008

Blocking Fugitive Cancer Cells By Stopping Blood Cells That Aid Them

Categorie : Blood / Hematology
Cancer cells get a helping hand from platelets, specialized blood cells involved in clotting. Platelets shelter and feed tumor cells that stray into the bloodstream, making it easier for cancer to spread, or metastasize. Research at Washington University School of Medicine in St. Louis suggests that ...

read more Cancer cells get a helping hand from platelets, specialized blood cells involved in clotting. Platelets shelter and feed tumor cells that stray into the bloodstream, making it easier for cancer to spread, or metastasize. Research at Washington University School of Medicine in St. Louis suggests that read more Wed Mar 2008 Wed Mar 2008

ProMetic Reports Continued Positive Data In PBI 1402 Phase II Trial In Chemotherapy Induced Anemia

Categorie : Blood / Hematology
ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announces favorable top-line findings from the third cohort in its Phase II trial with PBI-1402 in patients with chemotherapy-induced anemia ("CIA"). Analysis of the compiled data from a total of 18 patients showed an overall statistically signific ...

read more ProMetic Life Sciences Inc. (TSX: PLI) ( read more Wed Mar 2008 Wed Mar 2008

First Early Detection Blood Test For Parkinson's Shows Promise

Categorie : Blood / Hematology
A test that profiles molecular biomarkers in blood could become the first accurate diagnostic test for Parkinson's disease, new research shows. The screen relies on changes in dozens of small molecules in serum. These "metabolomic" alterations form a unique pattern in people with Parkinson's dise ...

read more A test that profiles molecular biomarkers in blood could become the first accurate diagnostic test for Parkinson's disease, new research shows. The screen relies on changes in dozens of small molecules in serum. These read more Wed Mar 2008 Wed Mar 2008

Totality Of Available Data Reaffirms PROCRIT(R) (Epoetin Alfa) Is Safe And Effective When Used Appropriately As Labeled To Treat Anemia

Categorie : Blood / Hematology
The totality of scientific data submitted in recent months to the U.S. Food and Drug Administration (FDA) in preparation for the March 13th Oncologic Drugs Advisory Committee Meeting (ODAC) reaffirms that erythropoiesis-stimulating agents (ESAs) are safe and effective when used according to the pr ...

read more The totality of scientific data submitted in recent months to the U.S. Food and Drug Administration (FDA) in preparation for the March 13th Oncologic Drugs Advisory Committee Meeting (ODAC) reaffirms that erythropoiesis-stimulating agents (ESAs) are safe and effective when used according to the pr read more Wed Mar 2008 Wed Mar 2008

Independent Data Safety Monitoring Board Recommends Continuation Of Sangart's Pivotal Phase III Trials Of Hemospan(R) Following Second Interim Review

Categorie : Blood / Hematology
Sangart, Inc., a privately held biopharmaceutical company focused on the research, development and commercialization of oxygen transport agents, announced that an independent data safety monitoring board (DSMB) has recommended the continuation of both Phase III clinical trials of Sangart's lead bloo ...

read more Sangart, Inc., a privately held biopharmaceutical company focused on the research, development and commercialization of oxygen transport agents, announced that an independent data safety monitoring board (DSMB) has recommended the continuation of both Phase III clinical trials of Sangart's lead bloo read more Wed Mar 2008 Wed Mar 2008

FDA Seeks Committee Opinion On Anti Anemia Drugs

Categorie : Blood / Hematology
The US Food and Drug Administration is to consult with its Oncologic Drugs Advisory Committee on Thursday this week on whether further restrictions and warnings should be placed on the use of a class of drugs used to treat anemia induced by chemotherapy.Erythropoiesis-stimulating agents, or ESAs, ar ...

read more The US Food and Drug Administration is to consult with its Oncologic Drugs Advisory Committee on Thursday this week on whether further restrictions and warnings should be placed on the use of a class of drugs used to treat anemia induced by chemotherapy.Erythropoiesis-stimulating agents, or ESAs, ar read more Wed Mar 2008 Wed Mar 2008

FDA Grants Priority Review For Promacta / Revolade (Eltrombopag)

Categorie : Blood / Hematology
GlaxoSmithKline announced that the United States Food and Drug Administration (FDA) has granted Priority Review for Promacta® / Revolade® (eltrombopag) for the short-term treatment of patients with chronic idiopathic thrombocytopenic purpura (ITP). Eltrombopag is an investigational, once-daily oral ...

read more GlaxoSmithKline announced that the United States Food and Drug Administration (FDA) has granted Priority Review for Promacta® / Revolade® (eltrombopag) for the short-term treatment of patients with chronic idiopathic thrombocytopenic purpura (ITP). Eltrombopag is an investigational, once-daily oral read more Wed Mar 2008 Wed Mar 2008

New Sepsis Treatment Reduces Length of Time in ICU

Categorie : Blood / Hematology
According to a recent article in the AmericanJournal of Respiratory and Clinical Care Medicine ICU stays, treatment duration, and hospital costs may be reducedif a blood test and a decision algorithm are used to determine how longpatients with severe sepsis or septic shock should receive antibiotict ...

read more According to a recent article in the AmericanJournal of Respiratory and Clinical Care Medicine ICU stays, treatment duration, and hospital costs may be reducedif a blood test and a decision algorithm are used to determine how longpatients with severe sepsis or septic shock should receive antibiotict read more Thu Mar 2008 Thu Mar 2008

EU Commission Approves Updated Prescribing Information For Aranesp(R)

Categorie : Blood / Hematology
Amgen (NASDAQ: AMGN) announced that the European Commission reached its final decision to amend the prescribing information for Aranesp® (darbepoetin alfa) based on the positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) in January 2008. The CHMP granted positive ...

read more Amgen (NASDAQ: AMGN) announced that the European Commission reached its final decision to amend the prescribing information for Aranesp® (darbepoetin alfa) based on the positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) in January 2008. The CHMP granted positive read more Thu Mar 2008 Thu Mar 2008

Consuming Alcohol May Lead To High Blood Pressure

Categorie : Blood / Hematology
People who drink regularly have higher systolic blood pressure thanpeople who do not, according to a recent article published in PLoSMedicine. Researcher Sarah Lewis (University ofBristol, UK) and colleagues report that systolic bloodpressure levels are about 7 mmHg higher in frequent drinkers than ...

read more People who drink regularly have higher systolic blood pressure thanpeople who do not, according to a recent article published in PLoSMedicine. Researcher Sarah Lewis (University ofBristol, UK) and colleagues report that systolic bloodpressure levels are about 7 mmHg higher in frequent drinkers than read more Thu Mar 2008 Thu Mar 2008

China Releases New Regulations That Aim To Strengthen Supervision, Management Of Blood Collection Centers

Categorie : Blood / Hematology
China's Ministry of Health on Friday released new regulations that aim to strengthen the supervision and management of blood collection centers in the country, China Daily reports. ...

read more China's Ministry of Health on Friday released new regulations that aim to strengthen the supervision and management of blood collection centers in the country, China Daily reports. read more Thu Mar 2008 Thu Mar 2008

From Combat To Consumer: New Bandage Stops Bleeding Fast

Categorie : Blood / Hematology
A new high-performance bandage made from the same blood-stopping technology the U.S. Army uses to save lives on the battlefields of Afghanistan and Iraq is now available to the public. When in direct contact with blood and pressure is applied, the KytoStat? Bandage does what traditional bandages do ...

read more A new high-performance bandage made from the same blood-stopping technology the U.S. Army uses to save lives on the battlefields of Afghanistan and Iraq is now available to the public. When in direct contact with blood and pressure is applied, the KytoStat? Bandage does what traditional bandages do read more Thu Mar 2008 Thu Mar 2008

Baxter Heparin Contaminant Found

Categorie : Blood / Hematology
The US Food and Drug Administration (FDA) announced yesterday, 5th March, they had found evidence that the heparin blood thinning product made by Baxter that has been linked to several deaths and serious reactions in hundreds of patients contains a contaminant that is hard to detect using standard t ...

read more The US Food and Drug Administration (FDA) announced yesterday, 5th March, they had found evidence that the heparin blood thinning product made by Baxter that has been linked to several deaths and serious reactions in hundreds of patients contains a contaminant that is hard to detect using standard t read more Thu Mar 2008 Thu Mar 2008

Circulite Reports Preliminary Results Of First-In-Man Pilot Study For Synergy(TM) Circulatory Assist Device

Categorie : Blood / Hematology
CircuLite?, Inc. announced preliminary top-line results of a pilot first-in-man study of four patients that have been implanted with the Synergy? Pocket Circulatory Assist Device. Synergy is a micro implantable blood pump, the size of a AA battery, that can be implanted superficially in a "pacemaker ...

read more CircuLite?, Inc. announced preliminary top-line results of a pilot first-in-man study of four patients that have been implanted with the Synergy? Pocket Circulatory Assist Device. Synergy is a micro implantable blood pump, the size of a AA battery, that can be implanted superficially in a read more Tue Mar 2008 Tue Mar 2008

Baxter Recalls All Heparin Vial Products

Categorie : Blood / Hematology
Baxter International Inc announced yesterday, Thursday 28th February, that it was recalling all remaining multi-dose and single-dose heparin sodium and HEP-LOCK heparin flush products now that alternative suppliers are able to meet national demand for them. Heparin sodium is a vital ingredient in s ...

read more Baxter International Inc announced yesterday, Thursday 28th February, that it was recalling all remaining multi-dose and single-dose heparin sodium and HEP-LOCK heparin flush products now that alternative suppliers are able to meet national demand for them. Heparin sodium is a vital ingredient in s read more Tue Mar 2008 Tue Mar 2008

Last Patient Enrolled In ATryn(R) Pivotal Study

Categorie : Blood / Hematology
GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced that ATryn(R) has completed enrollment in the pivotal study for the treatment of patients with hereditary antithrombin deficiency, or HD, undergoing high-risk surgical or childbirth procedures. As previously announced, the pivotal study has m ...

read more GTC Biotherapeutics, Inc. ( read more Tue Mar 2008 Tue Mar 2008

Mounting Evidence Of Increased Mortality From Drug Used By Anemic Cancer Patients

Categorie : Blood / Hematology
Millions of cancer patients take drugs to boost their red blood cells and health when they become anemic after chemotherapy. But a new study by Northwestern University's Feinberg School of Medicine shows these drugs, called erythropoiesis-stimulating agents (ESAs), actually raise patients' risk of d ...

read more Millions of cancer patients take drugs to boost their red blood cells and health when they become anemic after chemotherapy. But a new study by Northwestern University's Feinberg School of Medicine shows these drugs, called erythropoiesis-stimulating agents (ESAs), actually raise patients' risk of d read more Tue Mar 2008 Tue Mar 2008

New Consortium Announces Significant Grant Funding Of Anaemia Product Programme, UK

Categorie : Blood / Hematology
GlycoForm Ltd, PolyTherics Ltd, and Aston University announced that they have been awarded prestigious grants totalling £685,000 from the Technology Strategy Board and Biotechnology and Biological Sciences Research Council. This consortium is to use this additional funding over the next two years ...

read more GlycoForm Ltd, PolyTherics Ltd, and Aston University announced that they have been awarded prestigious grants totalling £685,000 from the Technology Strategy Board and Biotechnology and Biological Sciences Research Council. This consortium is to use this additional funding over the next two years read more Tue Mar 2008 Tue Mar 2008

Artisan Pharma's Lead Product, ART-123, Approved In Japan

Categorie : Blood / Hematology
Artisan Pharma, Inc. announced that the Japanese Pharmaceutical and Medical Device Agency approved Artisan's lead drug, ART-123 (human, soluble, recombinant thrombomodulin), on January 25, 2008 for the treatment of disseminated intravascular coagulation ("DIC") in Japan. The approval of ART-123, whi ...

read more Artisan Pharma, Inc. announced that the Japanese Pharmaceutical and Medical Device Agency approved Artisan's lead drug, ART-123 (human, soluble, recombinant thrombomodulin), on January 25, 2008 for the treatment of disseminated intravascular coagulation ( read more Tue Mar 2008 Tue Mar 2008

<<< previous | 3 | 4 | 5 | 6 | 7 | 8 | 9 next >>>



     


Custom Search